RxDoctor Payments Data

Andrew Rhinehart, MD

Family Medicine · Canal Winchester, OHNPI 1427360643

Payments from drug & device makers

$4,622in general payments, 2019–2025

Across 285 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$497
  • AbbVie$477
  • Novo Nordisk$454
  • Pfizer$349
  • Merck$250
  • Amgen$229
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$4,49897%
  • Education$1243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,622 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$102,979
Medicare patients
224
Services billed
9,407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban108$109,853
OzempicSemaglutide72$104,142
RybelsusSemaglutide44$66,857
TrulicityDulaglutide33$65,276
JardianceEmpagliflozin40$64,048
Tresiba Flextouch U-200Insulin Degludec35$48,990
XareltoRivaroxaban35$46,912
JanuviaSitagliptin Phosphate22$32,969
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$32,758
MounjaroTirzepatide19$26,122
FarxigaDapagliflozin Propanediol15$24,641
Janumet XrSitagliptin Phos/Metformin Hcl19$17,186
AbrysvoRsv Vacc, Pref A And Pref B/Pf43$13,948
Atorvastatin Calcium895$12,591
MyrbetriqMirabegron12$12,497

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$454$170,999116 claims
PfizerEliquis, Abrysvo$349$123,801151 claims
Lilly USA, LLCTrulicity, Mounjaro$497$91,39852 claims
Boehringer IngelheimJardiance$184$64,04840 claims
MerckJanuvia, Janumet Xr$250$50,15541 claims
Johnson & JohnsonXarelto$23$46,91235 claims
GSKTrelegy Ellipta, Shingrix$175$38,47747 claims
AstraZenecaFarxiga$174$24,64115 claims
Astellas Pharma US IncMyrbetriq$152$12,49712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Canal Winchester

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →